Seguir
Anna Balcerak
Anna Balcerak
Molecular biologist, Cancer Center Institute, Warsaw, Poland
Email confirmado em coi.waw.pl
Título
Citado por
Citado por
Ano
RNA–protein interactions: disorder, moonlighting and junk contribute to eukaryotic complexity
A Balcerak, A Trebinska-Stryjewska, R Konopinski, M Wakula, ...
Open biology 9 (6), 190096, 2019
1022019
The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients
LM Szafron, A Balcerak, EA Grzybowska, B Pienkowska-Grela, ...
Oncotarget 6 (41), 43897, 2015
542015
The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is Overexpressed in Highly Proliferating Tissues
LM Szafron, A Balcerak, EA Grzybowska, B Pienkowska-Grela, ...
PloS one 10 (5), e0127475, 2015
492015
Cell death by entosis: triggers, molecular mechanisms and clinical significance
M Kianfar, A Balcerak, M Chmielarczyk, L Tarnowski, EA Grzybowska
International Journal of Molecular Sciences 23 (9), 4985, 2022
172022
Optogenomic interfaces: Bridging biological networks with the electronic digital world
JM Jornet, Y Bae, CR Handelmann, B Decker, A Balcerak, A Sangwan, ...
Proceedings of the IEEE 107 (7), 1387-1401, 2019
172019
The significance of c. 690G> T polymorphism (rs34529039) and expression of the CEBPA gene in ovarian cancer outcome
B Konopka, LM Szafron, E Kwiatkowska, A Podgorska, A Zolocinska, ...
Oncotarget 7 (41), 67412, 2016
142016
HAX1 impact on collective cell migration, cell adhesion, and cell shape is linked to the regulation of actomyosin contractility
A Balcerak, A Trebinska-Stryjewska, M Wakula, M Chmielarczyk, ...
Molecular Biology of the Cell 30 (25), 3024-3036, 2019
132019
AMP-activated protein kinase (AMPK) as therapeutic target
E Sarnowska, A Balcerak, M Olszyna-Serementa, D Kotlarek, ...
Advances in Hygiene and Experimental Medicine 67, 750-760, 2013
132013
HAX-1: a novel p-body protein
V Zayat, A Balcerak, J Korczynski, A Trebinska, J Wysocki, E Sarnowska, ...
DNA and cell biology 34 (1), 43-54, 2015
122015
The interactome of multifunctional HAX1 protein suggests its role in the regulation of energy metabolism, de-aggregation, cytoskeleton organization and RNA-processing
M Wakula, A Balcerak, T Rubel, M Chmielarczyk, R Konopinski, F Lyczek, ...
Bioscience Reports 40 (11), BSR20203094, 2020
92020
Cytoplasmic HAX1 is an independent risk factor for breast cancer metastasis
A Trebinska-Stryjewska, L Szafron, A Rembiszewska, M Wakula, S Tabor, ...
Journal of Oncology 2019, 2019
82019
Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer
A Dansonka-Mieszkowska, LM Szafron, J Moes-Sosnowska, M Kulinczak, ...
Oncotarget 9 (25), 17735, 2018
82018
The calcium binding properties and structure prediction of the Hax-1 protein
A Balcerak, S Rowinski, L Szafron, E Grzybowska
Acta Biochimica Polonica 64 (3), 537-542, 2017
82017
Migracja i inwazyjność komórek nowotworowych; rola plastyczności komórek i udział macierzy zewnątrzkomórkowej w tworzeniu przerzutów
A Balcerak, M Wakuła, A Trębińska, EA Grzybowska
NOWOTWORY Journal of Oncology 66 (1), 45-52, 2016
62016
Kinaza białkowa aktywowana przez AMP (AMPK) jako cel terapeutyczny
E Sarnowska, A Balcerak, M Olszyna-Serementa, D Kotlarek, ...
Postępy Higieny i Medycyny Doświadczalnej 67, 750-760, 2013
42013
The CRNDE, VAV2 and CEBPA Genes as New Negative Prognosis Factors in Ovarian Cancer Patients
L Szafron, A Balcerak, EA Grzybowska, T Rubel, J Kupryjańczyk
European Journal of Cancer 49, 2013
32013
The RNA-binding landscape of HAX1 protein indicates its involvement in translation and ribosome assembly
A Balcerak, E Macech-Klicka, M Wakula, R Tomecki, K Goryca, ...
Cells 11 (19), 2943, 2022
22022
Quantification of cell-substrate adhesion area and cell shape distributions in MCF7 cell monolayers
M Wakula, A Balcerak, U Smietanka, M Chmielarczyk, R Konopiński, ...
JoVE (Journal of Visualized Experiments), e61461, 2020
22020
The RNA-binding landscape of HAX1 protein indicates its involvement in ribosome biogenesis and translation
A Balcerak, E Macech-Klicka, M Wakula, R Tomecki, K Goryca, ...
bioRxiv, 2022.01. 14.476349, 2022
2022
The mTOR kinase directly regulates FBP1 gene expression via interaction with SWI/SNF chromatin remodeling complex in clear cell renal cell carcinoma (ccRCC).
E Sarnowska, P Cwiek, J Szarkowska, M Leszczynski, N Rusetska, ...
European Urology Supplements 18 (8), e3056, 2019
2019
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–20